Found: 2
Select item for more details and to access through your institution.
RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 719, doi. 10.3390/cancers12030719
- By:
- Publication type:
- Article